Table 1.
Young control animals | Young diabetic animals | Old control animals | Old diabetic animals | |
---|---|---|---|---|
Endothelial membranes | ||||
Luminal | 0.28 ± 0.04 (278 μm) | 0.55 ± 0.06* (308 μm) | 1.02 ± 0.1* (246 μm) | 1.19 ± 0.09*† (214 μm) |
Abluminal | 0.33 ± 0.05 (181 μm) | 0.41 ± 0.05* (219 μm) | 0.79 ± 0.09* (179 μm) | 0.84 ± 0.08*† (146 μm) |
Podocyte membranes | ||||
Basal | 0.13 ± 0.03 (185 μm) | 0.27 ± 0.04* (233 μm) | 0.55 ± 0.06* (187 μm) | 0.56 ± 0.08*† (146 μm) |
Apical | 0.06 ± 0.01 (488 μm) | 0.19 ± 0.03* (547 μm) | 0.27 ± 0.03* (427 μm) | 0.33 ± 0.04*† (358 μm) |
Mesangial cell membranes | ||||
Cell processes | 0.76 ± 0.09 (317 μm) | 0.99 ± 0.12 (255 μm) | 2.55 ± 0.19* (354 μm) | 2.81 ± 0.19† (392 μm) |
Cell body | 0.56 ± 0.1 (92 μm) | 0.41 ± 0.12 (53 μm) | 0.59 ± 0.11 (78 μm) | 0.82 ± 0.23* (74 μm) |
Mitochondrial membranes | 0 (14 μm) | 0 (10 μm) | 0.05 ± 0.05 (16 μm) | 0.07 ± 0.07 (15 μm) |
Values are expressed as number of gold particles per μm (mean ± SEM). Numbers in parentheses indicate the total membrane length evaluated. Statistically significant differences (p<0.05) are indicated by (*) when compared to the corresponding membrane domain in the 3-month normoglycemic control group and (†) when the reference group is the 3-month diabetic rats (n = 3 animals/group). No significant differences were found between old control and old diabetic animals.